Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Mentara Therapeutics raised initial funding to advance its asset portfolio and launch a Phase 2 clinical study. Backed by SPRIM Global Investments and former shareholders of EuMentis Therapeutics.
Round Type
Venture
Investors
Description
Mentara Therapeutics, based in Melbourne, Australia, has successfully raised capital in its initial strategic financing round. The funds will be used to further develop its neurological therapies and scale up manufacturing operations. The company aims to conduct a Phase 2 clinical study for its lead drug candidate in patients with Parkinson's disease. Mentara is focused on treating neurodegenerative and neuropsychiatric diseases.
Fundz sees it the moment Mentara Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Mentara Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.